18 June 2025

Kirkland Advises Eli Lilly on Acquisition of Verve Therapeutics for up to $1.3 Billion

Advising firms

20 lawyers named

Lawyer	Firm	Seniority	Practice	Office
Keri Schick Norton	Kirkland & Ellis	Not stated	corporate	Not stated
Sarkis Jebejian	Kirkland & Ellis	Not stated	corporate	Not stated
Steven Choi	Kirkland & Ellis	Not stated	corporate	Not stated
Siqi Li	Kirkland & Ellis	Not stated	corporate	Not stated
Victor Simonte	Kirkland & Ellis	Not stated	corporate	Not stated
Anne Hicks	Kirkland & Ellis	Not stated	corporate	Not stated
Sharon Freiman	Kirkland & Ellis	Not stated	capital markets	Not stated
Sophia Hudson	Kirkland & Ellis	Not stated	capital markets	Not stated
Rebecca Cho	Kirkland & Ellis	Not stated	capital markets	Not stated
Ryan Paulish	Kirkland & Ellis	Not stated	capital markets	Not stated
Zach Stricklin	Kirkland & Ellis	Not stated	capital markets	Not stated
Andrea Murino	Kirkland & Ellis	Not stated	antitrust & Competition	Not stated
Margarita Karkantzou	Kirkland & Ellis	Not stated	antitrust & Competition	Not stated
Shellie Freedman	Kirkland & Ellis	Not stated	technology & IP transaction	Not stated
Rami Sherman	Kirkland & Ellis	Not stated	technology & IP transaction	Not stated
Andy White	Kirkland & Ellis	Not stated	technology & IP transaction	Not stated
Leonor Suarez	Kirkland & Ellis	Not stated	technology & IP transaction	Not stated
Rob Fowler	Kirkland & Ellis	Not stated	executive compensation	Not stated
Sally Ye	Kirkland & Ellis	Not stated	executive compensation	Not stated
Jenny Cha	Kirkland & Ellis	Not stated	executive compensation	Not stated

17 more lawyers on this deal. Register free to see the full deal team, with seniority, practice and office.

Want co-counsel patterns, repeat clients and alerts when these firms land their next deal? Get Pro.